jiangjingting
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma (NCT02992834) | jiangjingting | 2016-12-01 |
Track jiangjingting automatically
Every clearance here is in the API, with alerts when new ones post.